Protagonist Therapeutics (PTGX) Rose on Positive Trial Outcome
Carillon Tower Advisers, an investment management company, released its 'Carillon Eagle Small Cap Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. Small-cap stocks experienced a significant drop in Q1, with the Russell 2000 Growth Index (down 11.12%) trailing the Russell 2000 Value Index (down 7.74%). In the Russell 2000 Growth Index, real estate, which increased by 1.76%, outperformed all sectors both absolutely and relatively. The only other sector delivering positive returns was consumer staples, which rose by 0.67%. In addition, please check the fund's top five holdings to know its best picks in 2025.
In its first-quarter 2025 investor letter, Carillon Eagle Small Cap Growth Fund highlighted stocks such as Protagonist Therapeutics, Inc. (NASDAQ:PTGX). Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is a biopharmaceutical company. The one-month return of Protagonist Therapeutics, Inc. (NASDAQ:PTGX) was 2.86%, and its shares gained 50.15% of their value over the last 52 weeks. On May 23, 2025, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stock closed at $45.66 per share with a market capitalization of $2.83 billion.
Carillon Eagle Small Cap Growth Fund stated the following regarding Protagonist Therapeutics, Inc. (NASDAQ:PTGX) in its Q1 2025 investor letter:
"Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is a leading biotechnology company focused on developing drugs for rare and preventable diseases. The company has two key assets: rusfertide for the treatment of polycythemia vera (a type of blood cancer) and icotrokinra for the treatment of psoriasis and ulcerative colitis. During the first quarter, a major pharmaceutical company announced that icotrokinra met its primary endpoint in a phase 2 trial in patients with ulcerative colitis, achieving a clinical remission rate that is among the highest for oral therapies addressing this condition. This positive outcome contributed to the strong performance in the stock."
A research scientist wearing a lab coat working with precision in a biopharmaceutical laboratory.
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held Protagonist Therapeutics, Inc. (NASDAQ:PTGX) at the end of the first quarter, which was 37 in the previous quarter. While we acknowledge the potential of Protagonist Therapeutics, Inc. (NASDAQ:PTGX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains.
In another article, we covered Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and shared the list of best cancer stocks to invest in for long term gains. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Jim Cramer on APA Corporation: 'No Denying That Apache's Cheap Versus Its Assets'
APA Corporation (NASDAQ:APA) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. During the episode, Cramer commented that the stock is cheap as compared to its assets, as he said: 'Finally rounding things out… APA, the old Apache, [it] can run, but they can't hide. This is an oil and gas company, primarily natural gas. Apache's been a huge disappointment over the years. Maybe now that it's APA, it won't be. Well, anyway, maybe M&A's picking up. Workers in hard hats and safety gear processing oil and gas in a US refinery. APA (NASDAQ:APA) is an independent energy company engaged in the exploration, development, and production of natural gas, crude oil, and natural gas liquids, with additional global exploration and project interests. While we acknowledge the potential of APA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Jim Cramer on Coinbase Stock: 'I Think This One's Going Higher'
Coinbase Global, Inc. (NASDAQ:COIN) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. Cramer showed a bullish sentiment toward the stock and broader crypto group, as he said: 'Next, Coinbase. Alright, the cryptocurrency stocks, they just never want to quit. And this is a group that matters, even if older portfolio managers don't care [and] look the other way. I think this one's going higher, to who knows where.' A shot of someone securely accepting crypto assets as payment, showcasing the company's payment solutions. Coinbase Global, Inc. (NASDAQ:COIN) operates a platform for crypto assets, and it offers consumer accounts, institutional trading services, and developer tools for building onchain applications. In February, Cramer commented that he would prefer investors just buy Bitcoin instead of the company stock, as he said on February 4: 'Listen, sunshine, just go buy coin, just go buy the Bitcoin. Well, yeah. What do we do with the Coinbase? We don't want the Coinbase, we want the Bitcoin because that could be a, by the way, the, we make that special petroleum reserve slash Bitcoin reserve, that'll do better than Coinbase.' While we acknowledge the potential of COIN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Yahoo
13 minutes ago
- Yahoo
Jim Cramer on Enphase: 'A Roughed Up Solar Company'
Enphase Energy, Inc. (NASDAQ:ENPH) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. During the episode, Cramer called it a 'roughed up solar company,' as he said: 'At the top of that list, that sainted list today, Enphase Energy, oh boy, a roughed up solar company. Oh, it's driving that possible congressional break that could preserve some solar tax credits.' A solar panel array stretched across a large open field, its glimmering panels reflecting the sun. Enphase Energy (NASDAQ:ENPH) creates and sells smart energy systems that include microinverters, batteries, and software for monitoring and controlling solar power. Moreover, the company provides energy storage, EV charging, cloud-based services, and support for system design and permitting. In the first week of 2025, Cramer mentioned the company as he said: 'Finally, there's Enphase, which is a solar equipment company that has the misfortune of making some of its equipment in China. Given that Trump won over solar advocate Vice President Harris, we can expect that much higher tariffs are looming on Chinese goods. I think it's amazing that Enphase was only down 48% for the year. But hey, there's always 2025.' While we acknowledge the potential of ENPH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
